Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2008
11/27/2008WO2008141615A1 Use of auto-antibodies against cd28 as a prognostic marker in malignant melanoma
11/27/2008WO2008141480A1 Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof
11/27/2008WO2008141449A1 Single-domain antibodies and heavy chain antibody against egfr and uses thereof
11/27/2008WO2008141437A1 Reaction vessel with integrated optical and fluid control elements
11/27/2008WO2008141400A1 A novel aetiologic agent of acute gastroenteritis (age), diagnostic methods and therapeutic treatment thereof
11/27/2008WO2008141392A1 Use of a bioassay to validate efficacy
11/27/2008WO2008141358A1 Fragmentation profile based authentification of protein source
11/27/2008WO2008141351A1 Method for quantitatively determining analytes using a test element and test system and use thereof
11/27/2008WO2008124660A3 Methods and compositions for the treatment of cancer
11/27/2008WO2008124358A3 Detection of anaplasma platys
11/27/2008WO2008121375A3 Modified surfaces for immobilization of active molecules
11/27/2008WO2008121307A3 Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer
11/27/2008WO2008118413A3 Methods for detecting coronary artery disease
11/27/2008WO2008113017A3 Compositions, systems, and methods for preservation and/or stabilization of a cell and/or macromolecule
11/27/2008WO2008110624A3 Sirna-mediated silencing of genes for treating chemotherapeutic drug-resistant epithelial tumors
11/27/2008WO2008109968A3 Non destructive monitoring of polymer dynamics
11/27/2008WO2008107912A3 In vitro assay methods for classifying embryotoxicity of compounds
11/27/2008WO2008106115A3 Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
11/27/2008WO2008104380A3 Multiplex detection of tumour cells using a panel of agents binding to extracellular markers
11/27/2008WO2008103966A3 Compositions and methods using toll-like receptors and unc93b
11/27/2008WO2008103627A3 Renal monitor
11/27/2008WO2008101217A3 Device and method for automatic data acquisition and/or detection
11/27/2008WO2008098749A3 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof
11/27/2008WO2008092030A3 Specific n-terminal labeling of peptides and proteins in complex mixtures
11/27/2008WO2008091994A3 Mage-11 as a marker for endometrial receptivity to embryo transplantation and a marker and therapeutic target in castration-recurrent prostate cancer
11/27/2008WO2008089329A3 Novel activation and transfer cascade for ubiquitin
11/27/2008WO2008082979A3 Diagnostic test for the detection of a molecule or drug in whole blood
11/27/2008WO2008076806A3 Compositions and methods to potentiate colistin activity
11/27/2008WO2008070570A3 Positive selection of serum proteins for proteomic analysis
11/27/2008WO2008070227A3 A method for the identification of human immunodeficiency virus related antibodies in blood
11/27/2008WO2008069864A3 Mn/ca9 splice variants
11/27/2008WO2008066744A3 Methods and compositions for treating and preventing spinal cord injury and other neuronal disease or injury
11/27/2008WO2008064019A3 Methodologies, processes and automated devices for the orientation, sampling and collection of seed tissues from individual seed
11/27/2008WO2008063321A3 Gpr81-ligand complexes and their preparation and use
11/27/2008WO2008060841A3 Use of probes for unbound metabolites
11/27/2008WO2008059336A3 Method and apparatus for testing biological samples using a reader with a conductive housing
11/27/2008WO2008057437B1 Ex vivo flow cytometry method and device
11/27/2008WO2008055242A3 Early detection of diabetes
11/27/2008WO2008047129A3 Latent fluorescent probes
11/27/2008WO2008045323A3 Method for determination of dht levels in tissue samples
11/27/2008WO2008036474A3 A method to detect tumor markers and diagnosis of undifferenciated tumors
11/27/2008WO2008032153A3 Calreticulin for its use as a medication for the treatment of cancer in a mammal
11/27/2008WO2008024498A3 A system for obfuscating identity
11/27/2008WO2008016995A3 Methods of identifying modulators of insulin signalling
11/27/2008WO2008013975A3 Methods and kits for measurement of lymphocyte function
11/27/2008WO2008011193A3 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
11/27/2008WO2008008333A3 Bioassays for quality control of nutriceuticals that inhibit, upregulate or otherwise modulate translation initiation
11/27/2008WO2008006087A3 Antibodies to conformationally trapped proteins
11/27/2008WO2008005361A3 Embedded data dna sequence security system
11/27/2008WO2007140251A3 Apparatus and method for performing mass spectroscopy
11/27/2008WO2007139224A8 Method for detection of disease having insulin-resistant condition
11/27/2008WO2007137245A3 Systems and methods of microfluidic membraneless exchange using filtration of extraction fluid outlet streams
11/27/2008WO2007136782A3 Kits and methods for evaluating misfolded proteins
11/27/2008WO2007134167A9 Computational analysis of the synergy among multiple interacting factors
11/27/2008WO2007133702A3 Reagents for the detection of protein acetylation signaling pathways
11/27/2008WO2007133593A8 Methods, systems and computer programs for assessing chd risk using weighted hdl particle number measurements
11/27/2008WO2007130520A3 Cross-species and multi-species display systems
11/27/2008WO2007124105A3 Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
11/27/2008WO2007116336A9 Method and apparatus for monitoring alteration of flow characteristics in a liquid sample
11/27/2008WO2007106149A3 Intracellular isotope detection and uses thereof
11/27/2008WO2007104062A3 Compositions and methods based on peptide binding profiling
11/27/2008WO2007101002A3 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling
11/27/2008WO2007081385A8 Microfluidic devices and methods of use in the formation and control of nanoreactors
11/27/2008WO2007047924A3 Improved target ligand detection
11/27/2008WO2007016680A3 Phage-display plant defense peptides directed against phakopsora pachyrhizi and uromyces appendiculatus
11/27/2008WO2007010219A3 Methods for modulating a wnk i soform protein kinase activity
11/27/2008WO2006118986A3 Customized and dynamic association of probe type with feature extraction algorithms
11/27/2008WO2006086761A3 Methods of identifying genes which modulate myelination
11/27/2008WO2005030981A3 Homogeneous populations of molecules
11/27/2008US20080295185 Transgenic Mouse Models of Hepatitis C Virus (Hcv) and Identification of Hvc Therapeutics
11/27/2008US20080294351 Method for predicting secondary structure of nucleic acid sequence, a predictor for secondary structure of nucleic acid sequence and a predicting program for predicting secondary structure of nucleic acid sequence
11/27/2008US20080294349 Quantitative Evaluation and Image Analysis of Choroidal Neovascular Membrane and Other Retinal and Subretinal Lesions
11/27/2008US20080294028 Disease simulation system and method
11/27/2008US20080294025 Anti-Inflammatory Signal Molecules and Exercise
11/27/2008US20080293997 Chemical Sensor
11/27/2008US20080293926 Preparation of Biomolecules
11/27/2008US20080293925 Affinity Adsorbents for Plasminogen
11/27/2008US20080293921 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293665 Purine Nucleotide Derivatives
11/27/2008US20080293659 FC gamma RIIA-specific nucleic acid interference
11/27/2008US20080293627 Thyrotropin Receptor Preparations, Binding Regions Thereof, Antibody and Hormone Interactions Therewith, and Uses Thereof
11/27/2008US20080293625 Diagnosis of Inflammatory Bowel Diseases, More Particularly Ulcerative Colitis
11/27/2008US20080293620 Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections
11/27/2008US20080293595 siRNA targeting protein tyrosine phosphatase-1B (PTP1B)
11/27/2008US20080293593 siRNA targeting casitas B cell lymphoma-B (CBL-B)
11/27/2008US20080293592 Method For Covalently Immobilising Biomolecules on Organic Surfaces
11/27/2008US20080293590 Multianalyte assay method
11/27/2008US20080293586 Fluorescent probes for dna detection by hybridization with improved sensitivity and low background
11/27/2008US20080293583 Methods for diagnosing mood disorders
11/27/2008US20080293582 Markers and Methods for Assessing and Treating Ulcerative Colitis and Related Disorders Using a 43 Gene Panel
11/27/2008US20080293578 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
11/27/2008US20080293164 Fluorescent Methods and Materials for Directed Biomarker Signal Amplification
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080293162 Methods and compositions for diagnosing neoplastic disease
11/27/2008US20080293161 Detection of Carbohydrate Biomarkers
11/27/2008US20080293160 Dna and rna conformational switches as sensitive electronic sensors of analytes
11/27/2008US20080293159 Validation Process
11/27/2008US20080293158 Method And Apparatus For Improved Gas Detection
11/27/2008US20080293155 Salicylamide-lanthanide complexes for use as luminescent markers
1 ... 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 ... 3937